Articles On Integral Diagnostics (ASX:IDX)

ASX healthcare sector gains 1.99% in November while benchmark ASX 200 down 2.66% Mach7 rises 50% in November with health imaging stock outlining a growth strategy at its AGM  Island Pharmaceuticals rises after FDA confirms Galidesivir will...

Analysts at Macquarie believe there are several significant tailwinds for ASX All Ords healthcare stock Integral Diagnostics Ltd (ASX: IDX) in the coming year, and have a bullish price target on the company's shares. Integral Diagnostics...

The small side of the market has come under pressure recently amid increased volatility. While this is disappointing, it could have created a buying opportunity for investors with a high tolerance for risk. But which small cap ASX shares co...

Integral Diagnostics and Medadvisor have new CEOs after the latest round of changes at the top Mayne’s refrain: let the Takeovers Panel decide It’s a case of the MEGnificent Five as Compumedics sells another brain-scanning device in China...

ASX healthcare sector fell 4.83% in October and is down more than 19% YTD CSL shares fall more than 15% on October 28 after management trims FY26 guidance Nyrada surges 165% in October on board changes and progress in phase 2a trial    Wi...

Integral Diagnostics Ltd (ASX: IDX) shares are significantly undervalued, broker Bell Potter says, with total returns of more than 50% achievable over the next 12 months. The broker has a bullish price target of $4 per share on the imagi...

You make your own luck – and 4D Medical (ASX:4DX) has enjoyed that commodity in shovel-loads over the last month. It all started in August when the lung scanning innovator inked a deal with the giant ASX-listed Pro Medicus, involving a $10...

Strong growth in healthcare service provision in August signals good news for healthcare stocks, with Macquarie analysts tipping Integral Diagnostics Ltd (ASX: IDX) shares to pile on more than 20% in gains. Medicare statistics for Augu...

Highlights Key ASX companies are seeing rising and easing short positions this week Energy, retail, and technology names remain central to market attention Broader movements in the ASX stock market shape trading sentiment...

Highlights Multiple ASX-listed companies delivered corporate updates driving attention. Index reshuffles in ASX 200 and All Ordinaries reflected changing market trends. Global influences in energy, retail, and technology shaped invest...

If you are looking for investment ideas, then it could pay to listen to what Bell Potter is saying. That's because the broker has just released its latest top Australian picks for the month of September. It notes that its panel of favoured...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin A summary of the highlights from Broker Call Extra updates throughout the week past...

The S&P ASX 200 Health Care index fell 13.21% in August as a tough reporting season weighed on sector CSL had its biggest ever one day fall on August 19, down 17% following softer FY25 results and restructure plans Despite the broader...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin FNArena's Monitor keeps track of corporate earnings result releases, including broke...

The Integral Diagnostics Ltd (ASX: IDX) share price stormed 12% higher yesterday, closing the day at $3.05 a piece. In early afternoon trading today, the share price has dipped by a small 1.15%, but thanks to yesterday's surge, shares a...

Nanosonics shares gain up to 14% on better-than-expected numbers Investors applaud the early days of the Integral Diagnostics/Capitol Health merger Firebrick Pharma extends the reach of its nasal germ-buster Device maker Nanosonics (ASX:N...

The S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining momentum  Lumos soared 170% in July after six-year exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of Febri...

The Integral Diagnostics Ltd (ASX: IDX) share price opened 0.02% at $2.65 this morning. Over the past year, the company's shares have risen 6.85%. For context, the S&P/ASX All Ordinaries Index (ASX: XAO) is 0.59% lower this morning....

ASX healthcare shares form a core component of many Australian investors' portfolios. They are seen as offering essential services, and are therefore less susceptible to market volatility.  However, not all ASX healthcare stocks are c...

With ASX reporting season approaching soon, Australian investors may be looking for ASX healthcare stocks to add to their portfolio.  Yesterday, the S&P/ASX 200 Index (ASX: XJO) reached a new all-time high of 8,641 points.  The A...

The ASX 200 Health Care Index fell 1.05% in June and remains the worst performing sector YTD down 6.64% Morgans healthcare analyst Iain Wilkie said June likely saw some tax loss selling before EOFY  Amplia up 300% in June after complete re...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Discover the key differences between the ASX100 and ASX300 indices. Learn how each i...

Highlights Clarity Pharmaceuticals tops ASX 300 with double-digit gains Bannerman Energy posts the steepest loss among major decliners Broad-based sector volatility reflects dynamic trading conditions Daily trading on...

Doctor visits dipped in April, reversing a recovery trend Mayne Pharma threatens to go legal in takeover dispute … but peace erupts at Cann Group with settlement of legal spat   We’re either a healthy lot, rely on Dr Google or simply can’...

The S&P/ASX 200 Health Care Index rose 1.59% in May but remains worst performing sector YTD down 5.65% Morgans healthcare analyst Iain Wilkie said US President Donald Trump’s trade and health policies continue to impact sector Lumos up...

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares that leading...

If you have a high tolerance for risk and are on the hunt for big returns, then look no further. That's because analysts at Bell Potter have named the two small cap ASX shares listed below as buys with potential to deliver outsized returns....

Highlights ALS Limited delivers services in commodities and life sciences, showing growth despite margin contraction Nuix Limited maintains focus on software-based data discovery with revenue support from investigations and gover...

In this week’s video insight, I cover two major headlines that hit papers this week: Labor’s sweeping win in the federal election and Warren Buffett’s retirement as CEO of Berkshire Hathaway. Labor’s second-term agenda is set to reshape sec...

With Labor having secured a resounding Federal election win and a majority government, you may be wondering which S&P/ASX 200 Index (ASX: XJO) stocks are best placed to gain from upcoming policy rollouts. If so, you're not alone! The go...

Labor’s resounding victory at the weekend’s Federal Election, securing a second term with a strengthened parliamentary majority, defied predictions of a close contest, possibly reflects the idealism of a new generation of voters, and grants...

The US health sector shows signs of stabilising as chaos subsides Immutep will meet with the FDA following “excellent” follow-on trial results When it comes to its sagging share price, Immuron leaves blame-shifting to the defeated Liberals...

The S&P/ASX 200 Health Care Index rose 2.16% in April with the S&P/ASX 200 rallying 3.6% Morgans healthcare analyst Iain Wilkie said April was a marked improvement on recent months Several approvals during April, including for EBR...

Highlights: ASX200 ended higher with IT and Real Estate advancing, while Utilities and Energy retreated. Companies like IDX, JHX, and SFR trading well below estimated fair value based on discounted cash flow metrics. Key ind...

Highlights Several ASX-listed companies across diverse sectors are estimated to be trading below their intrinsic value Key businesses in infrastructure, diagnostics, and consumer services sectors reflect marked discount based on...

Highlights: Domino's Pizza Enterprises is priced below its estimated fair value based on cash flow metrics. LaserBond and Acrow show substantial gaps between market price and fair value estimates. Several industrial and heal...

Highlights: Regis Healthcare Ltd. (ASX:REG) has experienced significant growth, with its services spanning residential aged care, home care, and day therapy. Integral Diagnostics Ltd. (ASX:IDX) has faced a decline in share price,...

A new report from Macquarie offers ASX stock picks for three healthcare companies.  Regis Healthcare Ltd (ASX: REG) Regis Healthcare Ltd. engages in the provision of residential aged care services. It provides aged care facilities, re...

The All Ordinaries Index (ASX: XAO) is up 0.3% today, with plenty of help from one rocketing ASX All Ords stock. The fast-gaining company in question is 4DMedical Ltd (ASX: 4DX). Shares in the respiratory imaging technology company closed...

The ASX has been up 0.25% higher at 7,767 points. Kalgoorlie Gold Mining (ASX:KAL) has been among the most watched stock on HotCopper forums on discovery of primary gold mineralisation beneath the near-surface supergene gold blanket at i...

Highlights: Australian shares experience market fluctuations, leading to discussions about undervalued stocks. Companies with significant discounts based on estimated fair values are being examined. Various sectors, includin...

It’s up and go time for LTR in the US market All the budget healthcare news – and it’s a short item Prescient launches phase 2a study for a rare blood cancer   The developer of a nasal spray-mist erectile dysfunction (ED) treatment, LTR P...

Highlights: Several ASX-listed stocks have experienced declines, attracting attention for their market positions and operational outlooks. Companies in education, healthcare, and intellectual property services have shown developm...

Highlights: Several ASX-listed companies have experienced a decline in share value, presenting key insights into their financial performance. Macquarie's latest report outlines businesses expected to see operational improvements...

2025 has proven difficult for several beaten-down ASX shares. After the broad market selloff in February, much of the market has yet to recover in full. But this has opened the funding window to own passive interests in high-quality Aus...

Highlights: The S&P/ASX 200 Index has experienced a notable decline since mid-February 2025. Chris Stott of 1851 Capital has identified specific companies he believes have strong prospects. The current market environment presents...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck A compilation of stories relating to the February 2025 corporate repo...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin FNArena’s dedicated ESG Focus news section zooms in on matters Environmental, Social...

The ASX stock market has gone through one of the largest dips since the COVID crash. The S&P/ASX 200 Index (ASX: XJO) is down 8.5% since 14 February 2025. While market declines can be worrying, brave investors may find that some busines...

ASX small-cap shares can be exciting ideas if they have good growth potential. Businesses with smaller market capitalisations aren't followed by as many fund managers or brokers, so there's a higher chance they're undervalued by the mar...